Hualan Biological Vaccine Inc. (SHE:301207)
China flag China · Delayed Price · Currency is CNY
14.05
-0.15 (-1.06%)
Nov 17, 2026, 3:04 PM CST

Hualan Biological Vaccine Statistics

Total Valuation

SHE:301207 has a market cap or net worth of CNY 8.36 billion. The enterprise value is 5.10 billion.

Market Cap8.36B
Enterprise Value 5.10B

Important Dates

The last earnings date was Wednesday, October 28, 2026.

Earnings Date Oct 28, 2026
Ex-Dividend Date Nov 17, 2026

Share Statistics

SHE:301207 has 595.00 million shares outstanding. The number of shares has decreased by -0.17% in one year.

Current Share Class 595.00M
Shares Outstanding 595.00M
Shares Change (YoY) -0.17%
Shares Change (QoQ) -1.09%
Owned by Insiders (%) 0.26%
Owned by Institutions (%) 2.12%
Float 98.11M

Valuation Ratios

The trailing PE ratio is 180.79 and the forward PE ratio is 39.03.

PE Ratio 180.79
Forward PE 39.03
PS Ratio 11.99
PB Ratio 1.62
P/TBV Ratio 1.63
P/FCF Ratio 22.48
P/OCF Ratio 21.30
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 61.01, with an EV/FCF ratio of 13.72.

EV / Earnings 110.51
EV / Sales 7.31
EV / EBITDA 61.01
EV / EBIT n/a
EV / FCF 13.72

Financial Position

The company has a current ratio of 4.63, with zero debt.

Current Ratio 4.63
Quick Ratio 3.84
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 0.85% and return on invested capital (ROIC) is -2.82%.

Return on Equity (ROE) 0.85%
Return on Assets (ROA) -0.54%
Return on Invested Capital (ROIC) -2.82%
Return on Capital Employed (ROCE) -1.12%
Weighted Average Cost of Capital (WACC) 8.15%
Revenue Per Employee 985,037
Profits Per Employee 65,198
Employee Count708
Asset Turnover 0.10
Inventory Turnover 0.79

Taxes

Income Tax -14.33M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.64% in the last 52 weeks. The beta is 0.71, so SHE:301207's price volatility has been lower than the market average.

Beta (5Y) 0.71
52-Week Price Change -44.64%
50-Day Moving Average 17.44
200-Day Moving Average 18.51
Relative Strength Index (RSI) 28.56
Average Volume (20 Days) 7,691,972

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:301207 had revenue of CNY 697.41 million and earned 46.16 million in profits. Earnings per share was 0.08.

Revenue697.41M
Gross Profit 445.31M
Operating Income -57.99M
Pretax Income 31.83M
Net Income 46.16M
EBITDA 83.61M
EBIT -57.99M
Earnings Per Share (EPS) 0.08
Full Income Statement

Balance Sheet

The company has 3.26 billion in cash and no debt, with a net cash position of 3.26 billion or 5.48 per share.

Cash & Cash Equivalents 3.26B
Total Debt n/a
Net Cash 3.26B
Net Cash Per Share 5.48
Equity (Book Value) 5.16B
Book Value Per Share 8.68
Working Capital 3.95B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 392.45 million and capital expenditures -20.53 million, giving a free cash flow of 371.92 million.

Operating Cash Flow 392.45M
Capital Expenditures -20.53M
Depreciation & Amortization 141.60M
Net Borrowing n/a
Free Cash Flow 371.92M
FCF Per Share 0.63
Full Cash Flow Statement

Margins

Gross margin is 63.85%, with operating and profit margins of -8.32% and 6.62%.

Gross Margin 63.85%
Operating Margin -8.32%
Pretax Margin 4.56%
Profit Margin 6.62%
EBITDA Margin 11.99%
EBIT Margin -8.32%
FCF Margin 53.33%

Dividends & Yields

This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 11.39%.

Dividend Per Share 1.60
Dividend Yield 11.39%
Dividend Growth (YoY) 12.50%
Years of Dividend Growth 3
Payout Ratio 1,827.99%
FCF Payout Ratio 143.98%
Buyback Yield 0.17%
Shareholder Yield 11.56%
Earnings Yield 0.55%
FCF Yield 4.45%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for SHE:301207 is 25.57, which is 81.99% higher than the current price. The consensus rating is "Strong Buy".

Price Target 25.57
Price Target Difference 81.99%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) 14.18%
EPS Growth Forecast (3Y) n/a

Stock Splits

The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.

Last Split Date Jun 7, 2023
Split Type Forward
Split Ratio 1.5

Scores

SHE:301207 has an Altman Z-Score of 7.49 and a Piotroski F-Score of 4.

Altman Z-Score 7.49
Piotroski F-Score 4